rabeprazole has been researched along with Angioneurotic Edema in 2 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vovolis, V | 1 |
Christogianni, K | 1 |
Koutsostathis, N | 1 |
Chularojanamontri, L | 1 |
Jiamton, S | 1 |
Manapajon, A | 1 |
Suvanasuthi, S | 1 |
Kulthanan, K | 1 |
Dhana, N | 1 |
Jongjarearnprasert, K | 1 |
2 other studies available for rabeprazole and Angioneurotic Edema
Article | Year |
---|---|
Immunoglobulin E-mediated anaphylaxis to rabeprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anaphylaxis; Angioedema; Dimethindene; Drug Hypersens | 2010 |
Cutaneous reactions to proton pump inhibitors: a case-control study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Angioedema; Cas | 2012 |